Samuel
Senior Member (Voting Rights)
No one understands ME --- Chris Ponting's GWAS study (commencing next month?) might provide clues (in 6 months/year/18 months?).
yes being told "we completely understand" sets my teeth on edge.
No one understands ME --- Chris Ponting's GWAS study (commencing next month?) might provide clues (in 6 months/year/18 months?).
in case someone has tissue and heart problems (ACE) from covid (the spike protein), what vaccine would you think has least impact ?
perhaps the cuban abdala ?
It's not magic, the subunit is made by inserting the genetic sequence into other species eg yeast, moth larvae, plants, or cell culture, using some sort of tagging mechanism for extraction of the subunit and subsequent purification. Most subunit vaccines use whole proteins, eg a whole spike protein, or in the case of Influenza, neuraminidase and hemagglutinin.
Abdala is novel as if focused on the receptor-binding domain, rather than the whole spike protein, suggesting much of the efficacy (against symptomatic infection) is from blocking the virus from infecting cells in the first place.
I think this is some of the thinking behind the UK strategy with schools.I was particularly struck by the article accessible from that one:
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections | medRxiv
"Conclusions
This study demonstrated that natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity. Individuals who were both previously infected with SARS-CoV-2 and given a single dose of the vaccine gained additional protection against the Delta variant."
Perhaps not embark on unevidenced crusades that increase the fear people with ME/CFS have of Covid-19 vaccines?
Isn't this one way to encourage understanding and research into issues?
The point is, ANZMES did not provide good information. They amplified fear by providing misleading and unbalanced information.Being able to provide information won.
fyi I am not involved in ANZMES, so not my survey. But in my country.Does your survey, and the advice based on it..
I don't believe ANZMES has every advised its members to not have the vaccine. Rather they shared recommendations that experts considered that "that contracting COVID-19 poses a greater risk to health than the side effects of the vaccination".Any organisation that advises its members not to have potentially life saving vaccines on the basis of incomplete information is in my view irresponsible...
Yeah and I reckon they did with "Please note that this survey is classed as a self-report questionnaire which seeks to ascertain the subjective experience of people with ME/CFS and co-morbid conditions. The information collected is therefore anecdotal data. No clinical research has been conducted."Also they have a duty to report the flaws in their own data.
Thanks for clarifying that, RoseE.fyi I am not involved in ANZMES, so not my survey. But in my country.
I agree acknowledgement is important for those who are suffering, whether vaccine side effects or harm from the virus. But that's a different issue from publishing misleading surveys. I don't agree with ANZMES, the MEA, Solve or any other ME organisation publishing percentages from unscientific surveys in this context, nor with individuals regarded as experts by patients providing misleading information about ancedotal stories and unevidenced drugs. The context is too serious to be risking frightening people about the vaccine.I think there is a psychological principal about uncertainty creating fear and anxiety. Acknowledgement of a situation has a lot of value.
Yes, they did put disclaimers on things. But the fact remains that they shared information that increased concerns about the vaccination from influential people in the ME/CFS community. It's possible to do both.Yeah and I reckon they did with "Please note that this survey is classed as a self-report questionnaire which seeks to ascertain the subjective experience of people with ME/CFS and co-morbid conditions. The information collected is therefore anecdotal data. No clinical research has been conducted."
That's not what they did - they started campaigning for a fractionated dosing trial - including trying to get support for it via the survey. Just the suggestion of that will have made some people worried about having a full dose of the vaccine. It was left to the Ministry of Health to hose down that idea.I think there is a psychological principal about uncertainty creating fear and anxiety. Acknowledgement of a situation has a lot of value.
ME Auckland vice-President Kate Duder told RNZ several of her support group had their conditions triggered after being vaccinated. She said the group, alongside ANZMES, was now in talks with the Ministry of Health and Immunisation Advisory Centre (IMAC) about carrying out an alternative dosing trial involving four smaller doses instead of two standard doses. 'I have ME and react to a lot of things, so I've been very cautious about getting the vaccine when I can't even take supplements,' she said.
A Ministry of Health spokesperson said it was better for people with ME/CFS to get the vaccine than not get it. 'We completely understand the concerns of people with long-term conditions such as ME/CFS around vaccination. For these people the benefits of vaccination outweigh the risks of the effects of catching Covid-19 infection. Temporary medical exemptions application process under the Vaccinations Order is also open to general population with the same strict criteria applying.'
The spokesperson also questioned whether fractionated dosing would add to risks faced by those with pre-existing conditions. 'There is no current evidence that having four vaccinations will reduce side effects to vaccination. Indeed, it may increase the risk of side effects since the reactogenicity (which is the expected symptoms you get from your immune system such as headaches, fevers, flu-like symptoms) is expected to increase with each dose,' she said. 'There is no current information on what dose interval would work but it is evident that the time to complete a four-dose programme will be longer than a two-dose programme, meaning that this vulnerable group of people would be at risk of Covid-19 infection for longer.'
People were already worried before the survey.Just the suggestion of that will have made some people worried about having a full dose of the vaccine.
People were already worried before the survey.
Dr Vallings has stated in her clinical primer for clinicians that pwME should not get the influenza vaccine or any vaccination on a risk of relapse vs benefit. This also creates confusion and current research suggests that may not be so.